← Back to headlines
Novo Nordisk Partners with Cellular Intelligence on Parkinson's Therapy
Novo Nordisk has entered into a deal with Cellular Intelligence, a Zuckerberg-backed startup, to advance the development of Parkinson's cell therapy. This partnership sees Novo Nordisk handing over its Parkinson's drug development efforts to the AI-focused company.
11 May, 12:00 — 11 May, 15:30
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center1
Center (1)
bloomberg
Right2
Right (2)
jerusalem-postberlingske
Far R
Geographic diversity— 3 regions13/34
Israel1Denmark1US1
Sources
Showing 2 of 3 sources
bloombergHigh3h ago
Novo Hands Over Parkinson’s Therapy to Zuckerberg-Backed Startup - Bloomberg.com
Novo Hands Over Parkinson’s Therapy to Zuckerberg-Backed Startup Bloomberg.com
Read full article →jerusalem-postMostly Factual14m ago
Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy
'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic discovery with the uncompromising quality of a global pharmaceutical leader.'
Read full article →Coverage Timeline
First report: bloomberg · 11 May, 12:00|Full coverage: 3 · 4h|Window: 4h
Left-leaningCenterRight-leaning
